The effectiveness of afatinib, a second-generation EGFR-TKI, for NSCLC patients in clinical practice
CANCER SCIENCE(2018)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined